chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 58-year-old female patient who received SHINGRIX for prophylaxis. On 30th October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm, pain and chills. On an unknown date, the outcome of the pain in arm, pain and chills were recovered/resolved. It was unknown if the reporter considered the pain in arm, pain and chills to be related to SHINGRIX. Additional details were provided as follows: The patient experienced sore arm, aching and chills for 3 to 4 days and then those events resolved. The reporter did not gave consent to follow up. The reporter declined prescriber to follow up.
first mild tingling in mouth and scalp, and headachy feeling, then joint soreness all over for several days, also several days so far  of deep fatigue  (note joint soreness and fatigue continue as of this writing) - I THINK I am improving but not sure yet  pain at injection site for 3 days but that is almost gone now
Pt complains of severe pain and immobility of the arm 2 weeks after administration. Pt told to apply ice and take ibuprofen and to contact Physician.
Patient received the COVID-19 Moderna vaccine on 4/6/21 at 2:18pm. The following day on 4/7/21 at about 2:15pm, the patient was shopping in the store and fainted at self checkout. An associate caught her before she hit the ground and lowered her down gently. Store management alerted the pharmacy and I, the pharmacy manager, went to assist the patient. She said she felt fine yesterday after receiving the vaccine but did not feel well this morning. An ambulance was called and EMS arrived at the scene. One of them reported that her pulse was low but did not report a specific number. EMS took her to a local hospital. I spoke to her husband and let him know that I would call to follow up with them tomorrow.
Began developing symptoms during the day and by evening, entire upper arm was red, warm to touch, swollen, itchy and burning. Given Keflex and Zyrtec. Re-examined on 10/30/00 and much improvement with just slight redness and itching. States continues to improve.
small red bumps that itched appeared about 20Mar2021 which developed into blisters which were filled with blood or white fluid; small red bumps that itched appeared about 20Mar2021 which developed into blisters which were filled with blood or white fluid; small red bumps that itched appeared about 20Mar2021 which developed into blisters which were filled with blood or white fluid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 77 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 2021 (Lot number: EN6201) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Cardiac failure" (unspecified if ongoing), notes: other medical history: heart failure. Prior to vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication(s) included: ASPRIN; VIT B; VIT C; CARVEDILOL; ELIQUIS; ENTRESTO. Vaccination history included: Bnt162b2 (Dose Number: 1, Lot No: EN6199, Location of injection: Arm Left), administration date: 2021, when the patient was 77 years old, for COVID-19 immunization. The patient had not received any other vaccine within 4 weeks prior to the COVID-19 vaccine. The following information was reported: RASH PAPULAR (medically significant), PRURITUS (non-serious), BLISTER (non-serious) all with onset 20Mar2021, outcome "not recovered" and all described as "small red bumps that itched appeared about 20Mar2021 which developed into blisters which were filled with blood or white fluid". Therapeutic measures were taken as a result of rash papular, pruritus, blister. Treatment included 2 steroid injections and 500 MG of mycophenolate. Since the vaccination, the patient has not been tested for COVID-19.
Pt is experiencing body aches diffusely following immunization yesterday- SHINGRIX given to L deltoid. No pain to site of immunization but body aches as if he was getting the flu. He denies any other symptoms- no cold symptoms, no rashes, motor loss, neurosensory deficits, HA etc. No fever- checked on the call and 96.
He has Herpes for 40 years; the herpes that he had was gone after he took the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: ER8727) for covid-19 immunisation. The patient's relevant medical history included: "herpes" (unspecified if ongoing), notes: has Herpes for 40 years; the herpes that he had was gone after he took the vaccine. There were no concomitant medications. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "He has Herpes for 40 years; the herpes that he had was gone after he took the vaccine".  Additional information: The patient found the COVID cards where he took his shots. The first said the Pfizer BioNTech and its lot number is ER8727, expiration date is 22Mar2021 (Not clarified appropriately hence, not captured in tab). Then, got his next vaccine on 12Apr2021, with lot number: ER8729 (Clarified and captured in tab), expiration date is 12Apr2021 (Not clarified hence, not captured in tab). Third vaccine details were reported as took another dose, Lot number is FG3590, (20Oct2021). It was reported that the patient got more number which is on 26Apr2022. The patient was looking the lot number and it could be a 9. It did not on the top and its looks like a 9 and it's a Pfizer. F it might kind of look like a J. It could be FJ or FT4989 with expiration date reported as 26Sep2022 which was present on the card. The patient had one more shot which says a booster with lot number provided is GH9694, expiration date: 29Sep2022. He reported that he provided all the information which he had with him and reported that might be trouble in understanding the give details.   Follow-up attempts are completed. No further information is expected.
Large raised rash on arm for about 10 days. The skin area still itches. Low pounding in right ear once every few days or so that sometimes leads to headache.
Shortness of breath, spitting up blood, heart stopped and unable to resuscitate. All happened within a 20-minute time. No chest pains.
Shingles on right side of body(midline front wraped around to midline back) started 10/8/21, to walk in clinic on 10/10/21 for Valtrex, prednisone and gabapentin. as of today 10/20/21- rash continues even after treatment and now appears to be getting worse again.
Acute pain at injection site in upper right shoulder at bed time, the day I received vaccine. Next morning pain in both forearms both hands were stiff and swollen. After a week of no improvement took prednisone "6 pack", relieved symptoms but they returned 2 days after stopping prednisone. 2 months later symptoms mostly gone - still some swelling in hands pain in shoulder took a full month and a half for swelling to completely go away.
This spontaneous report was received from a female patient of unknown age regarding herself. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. On an unknown date, the patient experienced pain, redness and swelling at the injection site. The outcome of pain, redness and swelling at the injection site was unknown. The patient wanted to know exactly how long this adverse event would last. The patient was advised to speak further with her healthcare provider. The relatedness for all the events was unknown for ZOSTAVAX. Additional information has been requested.
Chest pains; severe headache; lost voice; low blood pressure; weakness; nausea; shakiness; bone ache; rash on arm.; This is a spontaneous report from a contactable consumer (patient).   A 72-year-old (non-pregnant) female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8734), via an unspecified route of administration at left arm on 12Apr2021 at 9:30 (at the age of 72-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history included giant cell arteritis and fibromyalgia. The patient had allergies with penicillin and percodan. The patient's concomitant medications included prednisone, LUMIGAN (bimatoprost), dorzolamide, fluoxetine and FAMO (famotidine). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207), via an unspecified route of administration at left arm on 22Mar2021 at 9:30 as dose 1, single for covid-19 immunisation. On 13Apr2021 at 01:00, the patient experienced chest pains, severe headache, lost voice, low blood pressure, weakness, nausea, shakiness, bone ache and rash on arm. The patient did not receive treatment for adverse event. The patient had not suffered from covid prior vaccination. The patient did not test covid post vaccination. The patient did not receive other vaccine in four weeks. The patient underwent lab tests and procedures which included blood pressure measurement: low on 13Apr2021. The outcome of the events was recovering.     No follow-up attempts are possible. No further information is expected
While going to bed felt like her right arm hurt and she began with a low grade fever and could not sleep due to the above symptoms.
pt recvd vax 19OCT95 & 24OCT95 pt exp sz;paramedics called; pt exp 2nd sz upon arrival & 3rd sz while in ER;devel dizziness & sl slurring of speech while in hosp;
Redness had increased; 2-2.5inch raised circle; Redness; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), INJECTION SITE PRURITUS (Itchiness), INJECTION SITE SWELLING (2-2.5inch raised circle) and INJECTION SITE ERYTHEMA (Redness had increased) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included METFORMIN HYDROCHLORIDE;SITAGLIPTIN, METFORMIN HYDROCHLORIDE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, ROSUVASTATIN;TELMISARTAN and KETOTIFEN for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itchiness). On 08-Mar-2021, the patient experienced ERYTHEMA (Redness) and INJECTION SITE SWELLING (2-2.5inch raised circle). On 09-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness had increased). At the time of the report, ERYTHEMA (Redness), INJECTION SITE PRURITUS (Itchiness), INJECTION SITE SWELLING (2-2.5inch raised circle) and INJECTION SITE ERYTHEMA (Redness had increased) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided
Rash on neck, torso and genital/leg area. Given prednisone, loratidine and betamethasone valerate oint.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Patient's medical history and concurrent conditions were not reported. On 28-JUL-2015, the patient was vaccinated with an expired dose of MMR II (lot # J008154, expiry date 08-JUL-2015 ). No adverse experienced was reported. Additional information has been requested.
woke up with moderate temperature of 101.3.  Body aches. chills not able move too much. Temperature today is 100.3
After vaccination, patient became dizzy, felt hot and c/o heart racing. Pt c/o having difficulty breathing 0.3cc epinephrine given IM. EMS called and pt transported to ER.
Severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Severe stomach pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049621A, 034F21A, 030B21A and 030M20A) for COVID-19 vaccination.     The patient neither had COVID positive test nor diagnosis.  Concurrent medical conditions included Vegetable allergy (night shade vegetables, red tomatoes, ripe potatoes) and Blood pressure abnormal.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ABDOMINAL PAIN UPPER (Severe stomach pain). At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach pain) outcome was unknown.            Concomitant medication of the patient included unspecified blood pressure medication.  No treatment information was provided by the reporter.
- visual disturbances (black dot and blurry vision) on drive home from vaccine - Fever (102.5), chills, extreme shaking started at 10:15pm and is still happening (tylenol is helping with the fever) - body aches in all joints - dizziness and lack of coordination / feeling confused  - went to pcp and they did a cognitive test and didnt see any reason for concern, although I am a healthcare provider myself (pharmacist) and I know something is very wrong. I might go to the hostpital, but dont  have great insurance so am uncertain
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0108AZ1A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal) and Hypertension. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), AMLODIPINE and ENALAPRIL for Hypertension.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.   This case was linked to MOD-2021-226228 (Patient Link).
RN reported 18 year-old student got severe abdominal cramps after 1st dose of VIVOTIF oral typhoid vaccine. Patient took 2nd dose, Dec. 10, 2012, cramps ongoing.
Developed Bell's Pally for the second time.  Also got Bell's Pally after the first Moderna Covid shot.  Pain behind and below right ear Difficulty closing right eye Can't  not whistle Can't puff out checks Droopy right side of face (mouth, nose, etc.)  Can't smile on right side of face Difficulty drinking and eating Difficulty talking Confusion Difficulty seeing out of right eye
This spontaneous report was received from a nurse and refers to a currently 36 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 21-JAN-2017 (at an unspecified hospital), the patient was vaccinated with M-M-R II (dose, frequency, route of administration, therapy type, lot # and expiration date were not reported) for prophylaxis. On 03-MAR-2017, the patient was given an additional booster of M-M-R II recombinant human albumin (rHA), lot # M017346, expiration date 06-APR-2018 (formulation, dose, frequency and route of administration were not reported) for an prophylaxis (at the reporter's office). No adverse effect was reported. The product quality complaint was not involved. Additional information has been requested.
fever; sick; did not get the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ILLNESS (sick) and PRODUCT DOSE OMISSION ISSUE (did not get the second dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), ILLNESS (sick) and PRODUCT DOSE OMISSION ISSUE (did not get the second dose). At the time of the report, PYREXIA (fever), ILLNESS (sick) and PRODUCT DOSE OMISSION ISSUE (did not get the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Vial were over the use by time. Set out of refrigerator on 4/18 7:50 a.m
I started having pain in both of my breast. They became swollen. It moved up under my arms into back and neck. I had a headache. My breast was tinder to the touch. I went to the doctor about it. They did a diagnostic monogram and ultrasound of both breasts done. I will give antibiotics and anti-inflammation medicine. The monogram was negative. Ultrasound normal. All my lymph nodes was tinder. I also had pain at the site of injection.
Covid like symptoms 8/ 2021. elevated D-dimer greater then 7300.   HA, vision and hearing loss- improved but still having HA - 9/3/2021- Stroke
p/vax pt exp shingles which were localized to the lt anterior thigh;pt sought unspecified medical attention;
upper left arm swollen 50% bigger, redness over half the upper arm, tender, painful, shoulder with injection site swollen to twice normal size
None. Pt. was given HIB component of PENTACEL mixed w/ sterile water and no DTaP/IPV component. No adverse effects. Will require repeat vaccination.
Pfizer-BioNTech COVID-19 Vaccine I experienced a seizure like nightmare.  There was a flash of bright light and then I started shaking  and moaning/gurgling.  I could only move my right leg to try to get my husbands attention but my arms and upper body were in paralysis.  I have never experienced anything close to this, but since I was sleeping,  I am not sure exactly what it was.  I believe it only lasted for about 30 seconds, and afterwards, I feel okay.
Admitted on 2/6/2. Arrives to Hospital from emergency services with falls from weakness causing rib fractures and covid.  Tested positive upon admission.
Dizziness 2 hours after vaccination, lasted up to 3 hours later. Chills and nausea 3 hours after vaccination, lasted 1-2 hours. Joint pain in hip 1 and 2 days after vaccination. Chills, fever, muscle fatigue 2 days after vaccination.
Got the flu shot around 5pm and around 8:30pm started feeling a little tickle in my throat.  The tickle started getting worse and i started coughing a lot.  Then it seemed like my throat was closing up.  I also started shivering and felt extremely cold (chills).  I began vomiting, my heartbeat was racing, my eyes were real red (on the white part) and watery.  I was also wheezing when i exhaled. I took two capsules of Benadryl and after about 20 minutes my throat felt better.  I was breathing better.  I still had chills and now had a fever of 101.8.  Most of the symptoms subsided but I have remained tired and fatigued feeling.  I have also had low grade fever off and on for 3 days now.  I went to see the doctor on Friday and she believes I did indeed have an allergic reaction to the flu shot.  I am also allergic to codeine and codone.
I had a headache, runny nose, tight throat, excess mucus. I took a home COVID-19 test that came back positive and called my Primary Care Physician. We discussed my taking the antiviral but felt that having to stop some of my other medications was not worth my my taking it since I was not feeling that bad. My blood oxygen is running 97 and 98 and I do not have a fever I am feeling better.
Patient got a headache and dizziness approximately 5 minutes after the vaccine. She stated after getting her BP checked several times after her onset of symptoms, she proceeded to say she has had a history of elevated BP in March 2021 and was evaluated by NP, at vaccine site already but since she had more normal BP readings than elevated readings, she decided to not put her on BP medicine. She also had an appointment with MD 5/14/2021 because she wanted to go to another doctor but now has decided to return to see LP at clinic. I called and made her an appointment with clinic for 2:15pm same day and her boyfriend was going to take her since it was already 12:30pm and it was close by our clinic. Phone call today to patient to check on her and she said she keep her appointment at Careconnect with, NP. She stated her BP was still elevated then as well around 150/98 while she was at MD office. Patient complained of a headache off and on until 10PM last night  on 5/13/2021 but feels much better today. She stated, NP and Dr, were going to discuss the medications for her to be on and get back with her but has not restarted medicines yet. She said they had prescribed Metformin a few months ago but Dr. at office took her off Metformin so she has not been taking it for two months now. She took her BP this morning at 9am and it was still 150/98 and is waiting for them to let her know what medications they are calling in for her.
Patient received the pediatric dose of Havrix instead of the adult dose. Patient did not experience any adverse effects. Patient was advised that they would need to start the series and the pediatric dose would be considered invalid. Patient received the  adult dose of Havrix the following day at the clinic.
Warm, redness and swollen left deltoid, small bruises at the site of IPV injection.
Mother stated nausea, vomiting, rash, fever swollen lymph nodes x2 days.
POST VACCINE, PATIENT C/O DIZZINESS. ASSISTED TO WC AND BROUGHT TO OBS. ASSISTED TO STRETCHER, PLACED IN TRENDELENBERG, REPORTS RELIEF AFTER A FEW MINUTES. VSS. SAT UP AND SNACK/WATER PROVIDED AS PATIENT ADMITS TO NOT EATING YET TODAY. ORTHOSTATIC VSS, ONCE S/S RESOLVED, ESCORTED TO EXIT WITH NO ISSUES AT 0845. 0810 LYING BP 112/65 HR 60 SATS 99% RA 0820 SITTING BP 121/64 HR 53 SATS 100% RA 0840 STANDING BP 126/71 HR 53 SATS 100%
pain in the veins that is different; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, unknown manufacturer.), for COVID-19 immunization. The following information was reported: VASCULAR PAIN (non-serious) with onset 17Nov2022, outcome "unknown", described as "pain in the veins that is different". Additional Information: Patient said he got the Pfizer bivalent vaccine on 16Nov2022 and then after two days, got pain in the veins that was different. He was querying if this was normal, or something was wrong.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.